---
title: "Roche purchases shares in tender offer for 89bio, Inc"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263440706.md"
description: "Basel, 30 October 2025 - Roche ( SIX: RO, ROG. OTCQX: RHHBY ) announced today that Roche's wholly owned subsidiary Bluefin Merger Subsidiary, Inc., has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common ..."
datetime: "2025-10-30T07:03:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263440706.md)
  - [en](https://longbridge.com/en/news/263440706.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263440706.md)
---

# Roche purchases shares in tender offer for 89bio, Inc

Basel, 30 October 2025 - Roche ( SIX: RO, ROG. OTCQX: RHHBY ) announced today that Roche's wholly owned subsidiary Bluefin Merger Subsidiary, Inc., has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common ...

### Related Stocks

- [ETNB.US](https://longbridge.com/en/quote/ETNB.US.md)
- [RHHBY.US](https://longbridge.com/en/quote/RHHBY.US.md)

## Related News & Research

- [FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment | RHHBY Stock News](https://longbridge.com/en/news/286594661.md)
- [BeOne's Venclexta challenger Beqalzi nets FDA approval](https://longbridge.com/en/news/286315985.md)
- [Switzerland's Roche agrees to acquire US-based PathAI](https://longbridge.com/en/news/285490796.md)
- [Roche enters into a definitive merger agreement to acquire PathAI to transform AI-driven diagnostics | RHHBY Stock News](https://longbridge.com/en/news/285486114.md)
- [Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS | RHHBY Stock News](https://longbridge.com/en/news/283568846.md)